EDGAR Filing Documents for 0001564590-17-011760

Form 8-K - Current report:

SEC Accession No. 0001564590-17-011760

Filing Date

2017-05-26

Accepted

2017-05-26 16:17:27

Documents

Period of Report

2017-05-25

Items

Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	aimt-8k_20170525.htm	8-K	43371
	Complete submission text file	0001564590-17-011760.txt		44545

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884

Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220

Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37519 | Film No.: 17874181
SIC: 2834 Pharmaceutical Preparations